For instance, inhibiting CSF1R signaling functionally reprograms macrophage responses to enhance antigen presentation and productive antitumor T cell responses in orthotopic grafted tumor PDA models (56). The gene discussed is CSF1R; the disease is Patent ductus arteriosus.